Imagion Biosystems Limited
Imagion Biosystems Limited provides medical imaging technologies using magnetic resonance. It is involved in the nanotechnology; biotechnology; and cancer diagnostics businesses. The company develops MagSense, which completed Phase 1 for the treatment of HER2 breast cancers, as well as advancing the research and development programs for prostate and ovarian cancer. It also develops PrecisionMRX, … Read more
Market Cap & Net Worth: Imagion Biosystems Limited (IBXXF)
Imagion Biosystems Limited (PINK:IBXXF) has a market capitalization of $4.91 Million ($4.91 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #34651 globally and #11311 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Imagion Biosystems Limited's stock price $0.01 by its total outstanding shares 490590239 (490.59 Million).
Imagion Biosystems Limited Market Cap History: 2020 to 2025
Imagion Biosystems Limited's market capitalization history from 2020 to 2025. Data shows change from $2.45 Billion to $4.91 Million (-70.12% CAGR).
Imagion Biosystems Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Imagion Biosystems Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
6.44x
Imagion Biosystems Limited's market cap is 6.44 times its annual revenue
0.68x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $2.45 Billion | $205.72K | -$5.36 Million | 11923.91x | N/A |
| 2021 | $492.55 Million | $2.86 Million | -$6.02 Million | 172.49x | N/A |
| 2022 | $1.96 Billion | $3.07 Million | -$9.81 Million | 639.01x | N/A |
| 2023 | $470.97 Million | $4.97 Million | -$12.47 Million | 94.75x | N/A |
| 2024 | $17.17 Million | $2.67 Million | -$2.07 Million | 6.44x | N/A |
Competitor Companies of IBXXF by Market Capitalization
Companies near Imagion Biosystems Limited in the global market cap rankings as of March 19, 2026.
Key companies related to Imagion Biosystems Limited by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #93 globally with a market cap of $174.19 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #150 globally with a market cap of $120.45 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #468 globally with a market cap of $45.61 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #507 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #93 | Thermo Fisher Scientific Inc | NYSE:TMO | $174.19 Billion | $464.69 |
| #150 | Danaher Corporation | NYSE:DHR | $120.45 Billion | $191.50 |
| #468 | IDEXX Laboratories Inc | NASDAQ:IDXX | $45.61 Billion | $577.12 |
| #507 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Imagion Biosystems Limited Historical Marketcap From 2020 to 2025
Between 2020 and today, Imagion Biosystems Limited's market cap moved from $2.45 Billion to $ 4.91 Million, with a yearly change of -70.12%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $4.91 Million | -71.43% |
| 2024 | $17.17 Million | -96.35% |
| 2023 | $470.97 Million | -76.00% |
| 2022 | $1.96 Billion | +298.41% |
| 2021 | $492.55 Million | -79.92% |
| 2020 | $2.45 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Imagion Biosystems Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.91 Million USD |
| MoneyControl | $4.91 Million USD |
| MarketWatch | $4.91 Million USD |
| marketcap.company | $4.91 Million USD |
| Reuters | $4.91 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.